FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
217242NDAARCUTIS001ZORYVEFOAM;TOPICAL0.3%ROFLUMILAST2023-12-15PrescriptionYes
215985NDAARCUTIS001ZORYVECREAM;TOPICAL0.3%ROFLUMILAST2022-07-29PrescriptionYes
002ZORYVECREAM;TOPICAL0.15%ROFLUMILAST2022-07-29PrescriptionYes